Download Files:
Batifiban
SKU
HY-125053-Get quote
Category Reference compound
Tags Cardiovascular Disease, Cytoskeleton, Integrin
Products Details
Product Description
– Batifiban, a cyclic peptide, is a platelet glycoprotein GPⅡb/Ⅲa antagonist, and inhibits platelet aggregation. Batifiban blocks circulating vitronectin binding to integrin ανβ3, Batifiban can be used for research of acute coronary syndromes[1].
Web ID
– HY-125053
Shipping
– Room temperature
Molecular Formula
– C34H47N11O9S2
References
– [1]Chen H, et al. Safety, pharmacokinetic and pharmacodynamic studies of batifiban injection following single- and multiple-dose administration to healthy Chinese subjects. J Huazhong Univ Sci Technolog Med Sci. 2009 Feb;29(1):12-8.
CAS Number
– 710312-77-9
Molecular Weight
– 817.94
SMILES
– O=C(N1[C@@](C(N[C@@H](CSSCCC2=O)C(N)=O)=O)([H])CCC1)[C@@H](NC([C@@H](NC(CNC([C@@H](N2)CCCNC(N)=N)=O)=O)CC(O)=O)=O)CC3=CNC4=CC=CC=C34
Clinical Information
– No Development Reported
Research Area
– Cardiovascular Disease
Solubility
– 10 mM in DMSO
Target
– Integrin
Pathway
– Cytoskeleton
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.